<DOC>
	<DOCNO>NCT02139930</DOCNO>
	<brief_summary>The main goal project compare two different approach reduce level nicotine cigarette : immediate reduction nicotine content cigarettes non-addictive level gradual reduction nicotine content cigarettes non-addictive level . These two approach contrast group continue smoke cigarette nicotine content similar conventional cigarette .</brief_summary>
	<brief_title>Project 2 : Strategies Reducing Nicotine Content Cigarettes</brief_title>
	<detailed_description>This project conduct compare product use pattern biomarkers exposure smoker assign ) gradual reduction reduce nicotine content ( RNC ) cigarettes ; b ) immediate reduction low nicotine content ( VLNC ) cigarettes c ) normal nicotine content ( NNC ) cigarettes . The outcome study provide information different approach reduce level nicotine cigarette determine approach optimal outcome take account balance overall risk reduction ( possibly maximize abrupt switch ) compliance acceptability ( possibly maximize gradual reduction RNC cigarettes ) .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>1 . Age 18+ 2 . Daily smoker smoke average least five cigarette per day least 1 year 3 . Breath CO level &gt; 8 ppm ( â‰¤ 8 ppm , NicAlert Strip level must indicate regular smoking ) 1 . Planned quit date next 30 day 2 . Currently seek treatment smoke cessation 3 . Currently use nicotine replacement therapy pharmacotherapies cessation aid ( noncessation intermittent use acceptable ) 4 . A quit attempt past 30 day result great 3 day abstinence 5 . Using tobacco product ecigarettes 9 day past 30 day 6 . Significant unstable medical condition ( Any significant change serious medical condition occur past 3 month include , cardiovascular disease , COPD , cancer , determine license medical professional site ) 7 . Unstable psychiatric condition ( Any significant change psychiatric symptom past 3 month determine license medical professional site ) 8 . Schizophrenia schizoaffective disorder 9 . Psychiatric medication change ( e.g. , new prescription , change dosage , discontinuation medication ) past 3 month result negative change symptom . 10 . Positive toxicology screen follow drug : cocaine , opiates , methadone , benzodiazepine , barbiturate , amphetamine , methamphetamine , PCP 1 . Marijuana test exclusionary criterion . 2 . Participants valid prescription opiate , benzodiazepine , barbiturate , amphetamine methadone exclude . 3 . Participants fail toxicology screen allow rescreen . 11 . Blood alcohol level &gt; 0.01 . Participants fail blood alcohol screen allow rescreen . 12 . Binge drink alcohol ( 9 day past 30 day , 4/5 drink per day ( female/male ) ) 13 . Pregnant , try become pregnant breastfeed 14 . Predominant use 'roll cigarette ' 15 . CO read &gt; 80 ppm 16 . Systolic BP great equal 160 . Participants fail blood pressure allow rescreen . 17 . Diastolic BP great equal 100 . Participants fail blood pressure allow rescreen . 18 . Systolic BP 90 symptomatic ( dizziness , extreme fatigue , difficulty thinking , inability stand walk , feel faint ) . Participants fail blood pressure allow rescreen . 19 . Diastolic BP 50 symptomatic ( dizziness , extreme fatigue , difficulty thinking , inability stand walk , feel faint ) . Participants fail blood pressure allow rescreen . 20 . Heart rate great equal 105 bpm . Participants fail heart rate allow rescreen . 21 . Heart rate lower 45 bpm symptomatic ( dizziness , extreme fatigue , difficulty thinking , inability stand walk , feel faint ) . Participants fail heart rate allow rescreen . 22 . Indicating suicidal ideation past month , suicide attempt past 5 year ( within past 5 10 year , require physician approval ) , score &gt; 4 MINI suicide subscale 23 . Household member enrol study concurrently . 24 . Inability independently read comprehend consent form write study material measure participant require complete part protocol home independently . 25 . Participated prior study involve reduced nicotine content cigarette . 26 . Having participate research study past three month study would impact baseline smoke response study product . 27 . Currently take follow anticonvulsant medication : 1 . Phenytoin [ Brand Name : Dilantin ] 2 . Carbamazepine [ Brand Name : Tegretol , Carbatrol , Equetro , Epitol ] 3 . Oxcarbazepine [ Brand Name : Trileptal ] 4 . Primidone [ Brand Name : Mysoline ] 5 . Phenobarbital 28 . Currently take follow medication : 1 . Bendamustine ( Treanda ) 2 . Clopidogrel ( Plavix ) 3 . Clozapine ( Clozaril , FazaClo ) 4 . Erlotinib ( Tarceva ) 5 . Flecainide ( Tambocor ) 6 . Fluvoxamine ( Luvox ) 7 . Irinotecan ( Camptosar ) 8 . Olanzapine ( Zyprexa ) 9 . Ropinirole ( Requip ) 10 . Tacrine ( Cognex ) 11 . Theophylline ( Theo Dur , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>smoking</keyword>
	<keyword>nicotine reduction</keyword>
</DOC>